$SBAC
SBA COMMUNICATIONS CORP

2024 Q2 Form 10-Q Financial Statement

#000103405424000005 Filed on May 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $660.5M $657.9M
YoY Change -2.66% -2.61%
Cost Of Revenue $141.3M $138.0M
YoY Change -8.42% -16.01%
Gross Profit $519.2M $519.9M
YoY Change -0.96% 1.69%
Gross Profit Margin 78.61% 79.02%
Selling, General & Admin $62.38M $68.70M
YoY Change -1.59% -4.86%
% of Gross Profit 12.01% 13.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $26.20M $37.50M
YoY Change -62.03% -79.44%
% of Gross Profit 5.05% 7.21%
Operating Expenses $62.38M $68.70M
YoY Change -1.59% -73.02%
Operating Profit $354.5M $323.4M
YoY Change 46.94% 26.02%
Interest Expense -$102.5M -$102.8M
YoY Change -6.14% -12.61%
% of Operating Profit -28.92% -31.79%
Other Income/Expense, Net -$207.4M -$151.9M
YoY Change 203.0% -504.41%
Pretax Income $147.1M $171.5M
YoY Change -14.86% 19.03%
Income Tax -$12.34M $16.93M
% Of Pretax Income -8.39% 9.87%
Net Earnings $162.8M $154.5M
YoY Change -20.04% 52.68%
Net Earnings / Revenue 24.65% 23.49%
Basic Earnings Per Share $1.52 $1.43
Diluted Earnings Per Share $1.51 $1.42
COMMON SHARES
Basic Shares Outstanding 107.4M 108.1M
Diluted Shares Outstanding 107.7M 108.6M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.5M $241.9M
YoY Change 9.16% 58.34%
Cash & Equivalents $220.5M $240.3M
Short-Term Investments $30.40M $1.585M
Other Short-Term Assets $17.71M $23.28M
YoY Change -25.62% -69.7%
Inventory
Prepaid Expenses
Receivables $88.65M $126.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $460.0M $447.6M
YoY Change -11.3% -5.08%
LONG-TERM ASSETS
Property, Plant & Equipment $2.720B $2.710B
YoY Change 0.28% -58.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $19.25M $22.02M
YoY Change -43.39% -40.6%
Other Assets $785.9M $806.5M
YoY Change -8.1% 4.58%
Total Long-Term Assets $9.326B $9.548B
YoY Change -7.53% -5.19%
TOTAL ASSETS
Total Short-Term Assets $460.0M $447.6M
Total Long-Term Assets $9.326B $9.548B
Total Assets $9.786B $9.995B
YoY Change -7.72% -5.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.74M $45.76M
YoY Change 7.89% -14.55%
Accrued Expenses $76.32M $77.04M
YoY Change -9.27% -80.31%
Deferred Revenue $3.109M $3.262M
YoY Change -73.94% -67.41%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.806B $1.805B
YoY Change 7426.27% 7422.48%
Total Short-Term Liabilities $2.460B $2.413B
YoY Change 233.1% 277.79%
LONG-TERM LIABILITIES
Long-Term Debt $10.47B $10.55B
YoY Change -16.69% -17.56%
Other Long-Term Liabilities $373.7M $411.4M
YoY Change 12.95% -82.39%
Total Long-Term Liabilities $12.60B $12.77B
YoY Change -15.54% -15.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.460B $2.413B
Total Long-Term Liabilities $12.60B $12.77B
Total Liabilities $15.06B $15.18B
YoY Change -3.81% -3.98%
SHAREHOLDERS EQUITY
Retained Earnings -$7.546B -$7.509B
YoY Change 2.49% 0.47%
Common Stock $1.075M $1.079M
YoY Change -0.83% -0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.317B -$5.223B
YoY Change
Total Liabilities & Shareholders Equity $9.786B $9.995B
YoY Change -7.72% -5.18%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $162.8M $154.5M
YoY Change -20.04% 52.68%
Depreciation, Depletion And Amortization $26.20M $37.50M
YoY Change -62.03% -79.44%
Cash From Operating Activities $425.6M $294.5M
YoY Change -12.59% -5.31%
INVESTING ACTIVITIES
Capital Expenditures $49.97M $57.87M
YoY Change -21.3% 17.78%
Acquisitions $41.62M $19.41M
YoY Change 110.1% -2.63%
Other Investing Activities -$71.24M $7.195M
YoY Change 47.79% -107.37%
Cash From Investing Activities -$121.2M -$85.31M
YoY Change 8.71% -41.87%
FINANCING ACTIVITIES
Cash Dividend Paid $108.1M
YoY Change 15.12%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -276.5M -191.4M
YoY Change -11.99% 170.63%
NET CHANGE
Cash From Operating Activities 425.6M 294.5M
Cash From Investing Activities -121.2M -85.31M
Cash From Financing Activities -276.5M -191.4M
Net Change In Cash 27.86M 13.39M
YoY Change -54.47% -85.68%
FREE CASH FLOW
Cash From Operating Activities $425.6M $294.5M
Capital Expenditures $49.97M $57.87M
Free Cash Flow $375.6M $236.6M
YoY Change -11.28% -9.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001034054
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-16853
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SBA COMMUNICATIONS CORPORATION
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0716501
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
8051 Congress Avenue
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
CY2024Q1 dei City Area Code
CityAreaCode
561
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
995-7670
CY2024Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
SBAC
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107443014
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240309000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208547000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
19892000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
38129000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
126525000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182746000
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
16535000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
16252000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44335000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38593000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
447596000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
484267000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2709681000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2711719000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2403849000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2455597000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2185851000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2240781000
CY2024Q1 sbac Acquired And Other Right Of Use Assets Net
AcquiredAndOtherRightOfUseAssetsNet
1441750000
CY2023Q4 sbac Acquired And Other Right Of Use Assets Net
AcquiredAndOtherRightOfUseAssetsNet
1473601000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
806539000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812476000
CY2024Q1 us-gaap Assets
Assets
9995266000
CY2023Q4 us-gaap Assets
Assets
10178441000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
45761000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
42202000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
77035000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92622000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1805395000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
643145000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
161127000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
235668000
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
32605000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
57496000
CY2024Q1 sbac Lease Liability Current
LeaseLiabilityCurrent
270318000
CY2023Q4 sbac Lease Liability Current
LeaseLiabilityCurrent
273464000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21048000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18662000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2413289000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1363259000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10550553000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11681170000
CY2024Q1 sbac Lease Liability Noncurrent
LeaseLiabilityNoncurrent
1806278000
CY2023Q4 sbac Lease Liability Noncurrent
LeaseLiabilityNoncurrent
1865686000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
411389000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
404161000
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
12768220000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13951017000
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
36577000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
35047000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107880000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107880000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108050000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108050000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1079000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1080000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2915215000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2894060000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7509379000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7450824000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-629735000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-615198000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5222820000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5170882000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9995266000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10178441000
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
628276000
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
617268000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29586000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58248000
CY2024Q1 us-gaap Revenues
Revenues
657862000
CY2023Q1 us-gaap Revenues
Revenues
675516000
CY2024Q1 sbac Cost Of Goods Sold Direct Operating Lease
CostOfGoodsSoldDirectOperatingLease
114813000
CY2023Q1 sbac Cost Of Goods Sold Direct Operating Lease
CostOfGoodsSoldDirectOperatingLease
120119000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23178000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44185000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68698000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72209000
CY2024Q1 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
7417000
CY2023Q1 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
6057000
CY2024Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
43648000
CY2023Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
26390000
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
76750000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
182415000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
334504000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
451375000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
323358000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
224141000
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
7314000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2816000
CY2024Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
96390000
CY2023Q1 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
101226000
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
8443000
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
14239000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5289000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4988000
CY2024Q1 sbac Gain Loss On Extinguishment Of Debt Including Interest Expense
GainLossOnExtinguishmentOfDebtIncludingInterestExpense
-4428000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44652000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37558000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-151888000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-80079000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
171470000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
144062000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16927000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43508000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
154543000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
100554000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-663000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
154543000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101217000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.43
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.42
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.93
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108102000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108132000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108616000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109271000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
154543000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
100554000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10868000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-22389000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25405000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16529000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
140006000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
94694000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-663000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
140006000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
95357000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5170882000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
154543000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-759000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21917000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
10868000
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
106157000
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-25405000
CY2024Q1 us-gaap Dividends
Dividends
106945000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5222820000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5276315000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101217000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-14716000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26701000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-22389000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
16529000
CY2023Q1 us-gaap Dividends
Dividends
93069000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-7112000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5269154000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
154543000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
100554000
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
76750000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
182415000
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-42980000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
41932000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
21469000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
26206000
CY2024Q1 sbac Noncash Asset Impairment And Decommission Costs
NoncashAssetImpairmentAndDecommissionCosts
38944000
CY2023Q1 sbac Noncash Asset Impairment And Decommission Costs
NoncashAssetImpairmentAndDecommissionCosts
26417000
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4428000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8283000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36320000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-16661000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-23883000
CY2024Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-51093000
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-9103000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
722000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4235000
CY2024Q1 sbac Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
34694000
CY2023Q1 sbac Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
37452000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-20395000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8904000
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
24783000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
25958000
CY2024Q1 sbac Increase Decrease In Long Term Lease Liability
IncreaseDecreaseInLongTermLeaseLiability
-37055000
CY2023Q1 sbac Increase Decrease In Long Term Lease Liability
IncreaseDecreaseInLongTermLeaseLiability
-34475000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-72437000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-15678000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
294453000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
311168000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19405000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19929000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57871000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49135000
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
311839000
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
213371000
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
311000000
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
213003000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7195000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
77329000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85310000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-146761000
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
125000000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
140000000
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
110000000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
185000000
CY2024Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2274825000
CY2024Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
2268000000
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
6000000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
106157000
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
108135000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
93933000
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
17091000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
11942000
CY2024Q1 sbac Payment Stock Option Net Share Settlements
PaymentStockOptionNetShareSettlements
17800000
CY2023Q1 sbac Payment Stock Option Net Share Settlements
PaymentStockOptionNetShareSettlements
26658000
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1764000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1079000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-191412000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-160728000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4345000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13386000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3899000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250946000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189283000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264332000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193182000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
121143000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
127094000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
7417000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
7000000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4861000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
7733000
CY2024Q1 sbac Operating Lease Modifications And Reassessments
OperatingLeaseModificationsAndReassessments
13520000
CY2023Q1 sbac Operating Lease Modifications And Reassessments
OperatingLeaseModificationsAndReassessments
12859000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
256000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 5pt;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The significant estimates made by management relate to the allowance for doubtful accounts, the costs and revenue relating to the Company’s construction contracts, stock-based compensation assumptions, valuation allowance related to deferred tax assets, fair value of long-lived assets, the useful lives of towers and intangible assets, anticipated property tax assessments, incremental borrowing rate for lease accounting, fair value of investments, and asset retirement obligations. Management develops estimates based on historical experience and on various assumptions about the future that are believed to be reasonable based on the information available. These estimates ultimately may differ from actual results and such differences could be material.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 5pt;text-indent: 0.50in;"><span id="_Hlk163735449" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the first quarter of 2024, the Company completed its assessment on the remaining estimated useful lives of its towers and intangible assets. The Company concluded through its assessment that it should modify its current estimates for asset lives based on its historical operating experience and the findings obtained by its independent consultant. The Company previously depreciated its towers on a straight-line basis over the shorter of the term of the underlying ground lease (including renewal options) taking into account residual value or the estimated useful life of the tower, which the Company had historically estimated to be </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years. Based on its assessment, the Company revised the estimated useful lives of its towers and certain related intangible assets (which are amortized on a similar basis to its tower assets, as their useful lives correlate to the useful life of the towers) from </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years, effective January 1, 2024. The Company accounted for the change in estimated useful lives as a change in estimate under ASC 250 “Accounting Changes and Error Corrections.” The impact of the change in estimate was accounted for prospectively effective January 1, 2024, resulting in a reduction in depreciation and amortization expense of approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">102.7</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">93.0</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million after tax, or an increase of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.86</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per diluted share) for the three months ended March 31, 2024. The change in useful lives is expected to reduce depreciation expense by approximately $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">411.5</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million ($</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">372.5</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million after tax, or an increase of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.43</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per diluted share) for the year ended December 31, 2024.</span></p>
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-28500000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
27400000
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
50700000
CY2024Q1 us-gaap Intercompany Foreign Currency Balance Amount
IntercompanyForeignCurrencyBalanceAmount
1200000000
CY2023Q4 us-gaap Intercompany Foreign Currency Balance Amount
IntercompanyForeignCurrencyBalanceAmount
1300000000
CY2024Q1 sbac Impairment Of Long Lived Assets Held For Use Additions
ImpairmentOfLongLivedAssetsHeldForUseAdditions
34552000
CY2023Q1 sbac Impairment Of Long Lived Assets Held For Use Additions
ImpairmentOfLongLivedAssetsHeldForUseAdditions
22332000
CY2024Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
4102000
CY2023Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1954000
CY2024Q1 sbac Other Asset Impairment Charges Including Third Pary Decommission Costs
OtherAssetImpairmentChargesIncludingThirdParyDecommissionCosts
4994000
CY2023Q1 sbac Other Asset Impairment Charges Including Third Pary Decommission Costs
OtherAssetImpairmentChargesIncludingThirdParyDecommissionCosts
2104000
CY2024Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
43648000
CY2023Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
26390000
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
22000000.0
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24500000
CY2023Q1 sbac Cost Method Invesment Impairment Loss
CostMethodInvesmentImpairmentLoss
0
CY2024Q1 sbac Cost Method Invesment Impairment Loss
CostMethodInvesmentImpairmentLoss
0
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
1600000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1000000.0
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
300000000
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
200000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240309000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
208547000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
264332000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250946000
CY2024Q1 us-gaap Restricted Investments
RestrictedInvestments
41900000
CY2023Q4 us-gaap Restricted Investments
RestrictedInvestments
42000000.0
CY2023Q4 sbac Collateral For Surety Payment And Performance Bonds
CollateralForSuretyPaymentAndPerformanceBonds
0
CY2024Q1 sbac Collateral For Surety Payment And Performance Bonds
CollateralForSuretyPaymentAndPerformanceBonds
0
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
66022000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
98674000
CY2024Q1 sbac Contract With Customer Estimated Earnings
ContractWithCustomerEstimatedEarnings
30418000
CY2023Q4 sbac Contract With Customer Estimated Earnings
ContractWithCustomerEstimatedEarnings
64589000
CY2024Q1 sbac Contract With Customer Billing To Date
ContractWithCustomerBillingToDate
83167000
CY2023Q4 sbac Contract With Customer Billing To Date
ContractWithCustomerBillingToDate
152608000
CY2024Q1 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
13273000
CY2023Q4 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
10655000
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
16535000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
16252000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3262000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5597000
CY2024Q1 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
13273000
CY2023Q4 sbac Contract With Customer Net Asset Liability
ContractWithCustomerNetAssetLiability
10655000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
1585000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
1046000
CY2024Q1 sbac Prepaid Real Estate Taxes
PrepaidRealEstateTaxes
3666000
CY2023Q4 sbac Prepaid Real Estate Taxes
PrepaidRealEstateTaxes
3522000
CY2024Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
4223000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
2102000
CY2024Q1 us-gaap Prepaid Taxes
PrepaidTaxes
8747000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
9064000
CY2024Q1 sbac Prepaid Rent Current
PrepaidRentCurrent
2832000
CY2023Q4 sbac Prepaid Rent Current
PrepaidRentCurrent
3712000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
23282000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19147000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
44335000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
38593000
CY2024Q1 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
417597000
CY2023Q4 us-gaap Deferred Rent Receivables Net Noncurrent
DeferredRentReceivablesNetNoncurrent
415100000
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
93514000
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
104674000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
155580000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
148104000
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8706000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
8713000
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
22020000
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
24540000
CY2024Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
44529000
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
43872000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
806539000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812476000
CY2024Q1 sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
10295000
CY2023Q1 sbac Towers And Related Intangible Assets Acquisitions
TowersAndRelatedIntangibleAssetsAcquisitions
12780000
CY2024Q1 sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
9110000
CY2023Q1 sbac Ground Lease Land Purchases
GroundLeaseLandPurchases
7149000
CY2024Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19405000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19929000
CY2024Q1 sbac Ground Lease Extensions
GroundLeaseExtensions
4600000
CY2023Q1 sbac Ground Lease Extensions
GroundLeaseExtensions
5100000
CY2024Q1 sbac Performance Targets Maximum Potential Obligation
PerformanceTargetsMaximumPotentialObligation
16400000
CY2023Q4 sbac Performance Targets Maximum Potential Obligation
PerformanceTargetsMaximumPotentialObligation
17900000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6969794000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6959501000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4260113000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4247782000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2709681000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2711719000
CY2024Q1 us-gaap Depreciation
Depreciation
37500000
CY2023Q1 us-gaap Depreciation
Depreciation
69400000
CY2023Q4 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
6500000
CY2024Q1 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
6500000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7130569000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4726720000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2403849000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7179789000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4724192000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2455597000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27100000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101800000
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
14671000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
25630000
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
7961000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
7149000
CY2024Q1 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
6524000
CY2023Q4 sbac Capital Expenditure Accrual Current
CapitalExpenditureAccrualCurrent
6477000
CY2024Q1 sbac Accrued Holdbacks
AccruedHoldbacks
14295000
CY2023Q4 sbac Accrued Holdbacks
AccruedHoldbacks
16100000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33584000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37266000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
77035000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
92622000
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
12435000000
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
11526747000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
12355948000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
12388000000
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
11480332000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
12324315000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1805395000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
643145000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10550553000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
11681170000
CY2024Q1 sbac Cash Interest Expense
CashInterestExpense
96390000
CY2024Q1 sbac Noncash Interest Expense
NoncashInterestExpense
8443000
CY2023Q1 sbac Cash Interest Expense
CashInterestExpense
101226000
CY2023Q1 sbac Noncash Interest Expense
NoncashInterestExpense
14239000
CY2023 sbac Line Of Credit Facility Margin Adjustment
LineOfCreditFacilityMarginAdjustment
0.00050
CY2023 sbac Line Of Credit Facility Commitment Fee Adjustment
LineOfCreditFacilityCommitmentFeeAdjustment
0.00010
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
214.33
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
106100000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1340000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
168.32
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
153000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
125.67
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1187000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
173.82
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M12D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
52211000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1161000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
172.14
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
52211000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
26000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
248.41
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14200000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
382300000
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Revenues
Revenues
657862000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
137991000
CY2024Q1 us-gaap Gross Profit
GrossProfit
519871000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68698000
CY2024Q1 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
7417000
CY2024Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
43648000
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
76750000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
323358000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-151888000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
171470000
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
77276000
CY2023Q1 us-gaap Revenues
Revenues
675516000
CY2024Q1 sbac Contribution From Joint Venture Partner
ContributionFromJointVenturePartner
1530000
CY2023 sbac Contribution From Joint Venture Partner
ContributionFromJointVenturePartner
1200000
CY2023 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
7408000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
164304000
CY2023Q1 us-gaap Gross Profit
GrossProfit
511212000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72209000
CY2023Q1 sbac Business Combination Acquisition Related Costs And Adjusments
BusinessCombinationAcquisitionRelatedCostsAndAdjusments
6057000
CY2023Q1 sbac Asset Impairment And Decommission Costs
AssetImpairmentAndDecommissionCosts
26390000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
182415000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
224141000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-80079000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
144062000
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
69320000
CY2024Q1 us-gaap Assets
Assets
9995266000
CY2023Q4 us-gaap Assets
Assets
10178441000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
154543000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
101217000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108102000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108132000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
514000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1139000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108616000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109271000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.43
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.94
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.42
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.93
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
35047000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
31735000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4397000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest
899000
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
36577000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
35047000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001034054-24-000005-index-headers.html Edgar Link pending
0001034054-24-000005-index.html Edgar Link pending
0001034054-24-000005.txt Edgar Link pending
0001034054-24-000005-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sbac-20240331.xsd Edgar Link pending
sbac-20240331x10q.htm Edgar Link pending
sbac-20240331xex31_1.htm Edgar Link pending
sbac-20240331xex31_2.htm Edgar Link pending
sbac-20240331xex32_1.htm Edgar Link pending
sbac-20240331xex32_2.htm Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
sbac-20240331_cal.xml Edgar Link unprocessable
sbac-20240331_def.xml Edgar Link unprocessable
sbac-20240331_lab.xml Edgar Link unprocessable
sbac-20240331_pre.xml Edgar Link unprocessable
sbac-20240331x10q_htm.xml Edgar Link completed